PQA 06 - Radiation and Cancer Biology, Health Care Access and Engagement

Presentations

• 05:00pm - 06:00pm PT

  Physician Expertise and Patient Access to Intensity Modulated Radiotherapy for Head and Neck Cancer

  Speaker: Xuguang Chen, MD, PhD - University of North Carolina, Chapel Hill
• 05:00pm - 06:00pm PT

  A Geographic Comparison of the Medical Physics Job Market and Accredited Residency Program Distribution

  Speaker: Fatima Madondo, BS, student - Geisel School of Medicine at Dartmouth, Lebanon
• 05:00pm - 06:00pm PT

  ß-Trcp and RSK2-Mediated Proteolysis of FOXN3 Facilitates BRCA1-Dependent DNA Damage Repair and Radioresistance in Lung Cancer

  Speaker: Shuangbing Xu, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
• 05:00pm - 06:00pm PT

  Clinical Characteristics and Incidence of Radiation-Induced Sarcoma in Cancer Patients

  Speaker: Hao Wang, MD, PhD - Peking University Third Hospital, Beijing
• 05:00pm - 06:00pm PT

  Optimal Treatment Sequence for CDK4/6 Inhibitors and Radiation Combination Therapy in Triple Negative and Estrogen Receptor Positive Breast Cancer

  Speaker: Courtney Pisano, DO, MS, MPH - UH Seidman Cancer Center Case Western Reserve University, Cleveland
• 05:00pm - 06:00pm PT

  Inhibition of ATM and xCT Enhances Radiation Sensitivity and Suppresses Tumor Growth in Glioblastoma

  Speaker: Mi Youn Seol, MS - Yonsei University College of Medicine, Seoul
• 05:00pm - 06:00pm PT

  Inhibition of de novo Lipogenesis through Acly and FASN Sensitizes PDAC to RT and Ferroptosis

  Speaker: Adam Mueller, MD, PhD - UPMC Cancer Center, Pittsburgh
• 05:00pm - 06:00pm PT

  The Orphan Gene CCDC97 is Involved in DNA Damage Response and Ferroptosis Modulation

  Speaker: Mauro Loi, MD - Azienda Ospedaliera Universitaria Careggi, Florence
• 05:00pm - 06:00pm PT

  Carbon Ion Therapy-Induced Local Control of Pancreatic Cancer is Dependent on the Presence of the Adaptive Anti-Tumor Immunity

  Speaker: Saleh Eskandarian, - Deutsches Krebsforschungszentrum, Heidelberg
• 05:00pm - 06:00pm PT

  Inhibition of Cholinergic Signaling Enhances Radiation Treatment Efficacy in Glioblastoma

  Speaker: Ayanfeoluwa Kolawole, BS - Geisel School of Medicine at Dartmouth, Lebanon
• 05:00pm - 06:00pm PT

  Mapping Single-Cell ecDNA Dynamics in Glioblastoma with CRISPR Lineage Tracing

  Speaker: Abigail Marshall, BS - Geisel School of Medicine at Dartmouth, Lebanon
• 05:00pm - 06:00pm PT

  STARBURST: Phase 2 study of ⁸⁹Zr-girentuximab for PET imaging of solid tumors likely to express high levels of carbonic anhydrase IX (CAIX)

  Speaker: Frankis Almaguel, - Biogenix Molecular, Miami
• 05:00pm - 06:00pm PT

  Proton Therapy in Latin America: Urgent Need for Investment and Strategic Implementation

  Speaker: Marcos Santos, MD, PhD - ALATRO, Brasilia
• 05:00pm - 06:00pm PT

  Enhanced Detection of Rare Cells in Hodgkin Lymphoma Using Tabmap for Single-Cell RNA Sequencing Analysis

  Speaker: Andrew Heider, BS - Stanford University, San Jose
• 05:00pm - 06:00pm PT

  The Role of SIRT2 in Oral Stem Cell Resilience in Radiation Mucositis

  Speaker: Eva Allen, - Department of Radiation Oncology, University of Arkansas for Medical Sciences, LITTLE ROCK
• 05:00pm - 06:00pm PT

  Quercetin, a Natural Flavonoid Compound, Sensitizes Pancreatic Ductal Adenocarcinoma to Radiation Therapy

  Speaker: Vishwa Gandhi, PhD - UPMC Cancer Center, Pittsburgh
• 05:00pm - 06:00pm PT

  Management of Succinate Dehydrogenase-Mutant Paraganglioma with Stereotactic Radiosurgery

  Speaker: Paul Harary, BS - Stanford University School of Medicine, San Jose
• 05:00pm - 06:00pm PT

  Differential Gene Expression in Patients with or without Downstaging Following Neoadjuvant CRT in Esophageal Cancer

  Speaker: Lou-Anne Acevedo, MD - Medical College of Wisconsin, Milwaukee
• 05:00pm - 06:00pm PT

  Integrating Functional and Computational Approaches to Precision Medicine for Medulloblastoma

  Speaker: Geoffrey Sedor, MD, MS, BS - NewYork-Presbyterian Hospital Columbia, New York
• 05:00pm - 06:00pm PT

  Molecular and Immune Signatures of Early-Onset Prostate Cancer: Implications for Tumor Biology and Treatment Approaches

  Speaker: Raksha Narasimhan, BS - University of Miami Miller School of Medicine, Miami
• 05:00pm - 06:00pm PT

  High Environmental L-Lactate Facilitates DNA Damage Repair Pathway by Inducing Lactylation in Cervical Carcinoma Cells

  Speaker: Dalissa Negrón-Figueroa, BS - MD Anderson Cancer Center, Houston
• 05:00pm - 06:00pm PT

  Modeling RT-Induced Immune Priming to Optimize Immunotherapy Timing in Radiotherapy

  Speaker: Daisuke Kawahara, PhD - Hiroshima University, Hiroshima
• 05:00pm - 06:00pm PT

  High-Dose Ionizing Radiation Induces Mitochondrial Dysfunction, Mitophagy, Apoptosis, and Synaptic Plasticity Loss in Cultured Primary Rat Cortical Neurons

  Speaker: Sheng-Yow Ho, MD, MS - Chi Mei Medical Center , Tainan
• 05:00pm - 06:00pm PT

  Job Turnover Among Radiation Oncologists: 2015 to 2023

  Speaker: Sifan Lu, BA - Maimonides Medical Center/SUNY Downstate HSU, Brooklyn
• 05:00pm - 06:00pm PT

  COPS8-Mediated Deneddylation of DHX9 Enhances Radioresistance in Non-Small Cell Lung Cancer via Facilitating DNA Damage Repair

  Speaker: Shunshun Bao, - Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical, Jinan
• 05:00pm - 06:00pm PT

  Overcoming Radioresistance in Hepatocellular Carcinoma through Ferroptosis Modulation and Exosomal Biomarkers

  Speaker: Ping-Hsiu Wu, MD - Hokkaido University, Sapporo 060-8638
• 05:00pm - 06:00pm PT

  Antitumor Effect of PRaG Therapy in a Triple-Negative Breast Cancer Model

  Speaker: Jiaqi Zhang, - Center for Cancer Diagnosis and Treatment, The Second Af?liated Hospital of Soochow University, Suzhou
• 05:00pm - 06:00pm PT

  Reducing Fibrosis with Tumor Treating Fields

  Speaker: Emma Higgins, BS - Franciscan University of Steubenville, Steubenville
• 05:00pm - 06:00pm PT

  Effect of Cyclin E Overexpression on Anti-Tumor Immune Responses Via Activation of the cGAS/STING Pathway Following Radiotherapy

  Speaker: Yun Wu, - Center for Cancer Diagnosis and Treatment, The Second Af?liated Hospital of Soochow University, Suzhou
• 05:00pm - 06:00pm PT

  Radiation Revitalizes Anti-PD-1 Efficacy by Removing Immune Suppression in the Tumor Draining Lymph Nodes of Metastatic TNBC

  Speaker: Monika Quackenbush, BS - Salk Institute for Biological Studies, La Jolla
• 05:00pm - 06:00pm PT

  The Molecular Mechanism of RCC1 - Mediated Promotion of Ferroptosis and Enhancement of Oxaliplatin Sensitivity via the ATM Pathway in Colorectal Cancer

  Speaker: Yujie Zhao, - Peking University Shenzhen Hospital, Shenzhen
• 05:00pm - 06:00pm PT

  Targeting Tumor Cell MALT1 Reprograms Tumor Microenvironment via Macrophage M1 Polarization and Overcomes Radioresistance in NSCLC

  Speaker: Shunshun Bao, - Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical, Jinan
• 05:00pm - 06:00pm PT

  Targeting CD70 Enhances Radiosensitivity and Modulates Immune Microenvironment in Non-Small Cell Lung Cancer

  Speaker: Chen Tian, PhD - Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical, Jinan
• 05:00pm - 06:00pm PT

  The Protective Effect of Targeting AQP4 on Acute Radiation-Induced Brain Injury in Rats: Reducing Brain Edema, Inflammation, Apoptosis and Maintaining the Integrity of Blood-Brain Barrier

  Speaker: Yaozu Xiong, PhD - Department of Radiotherapy for Oncology, The First Affiliated Hospital of 8 Soochow University, Suzhou
• 05:00pm - 06:00pm PT

  Comparison of Colon vs. Anal Cancer Stigma among Persons with HIV

  Speaker: Nicholas Bader, MD - Emory University School of Medicine, Atlanta
• 05:00pm - 06:00pm PT

  A Comparative Study of Automated and Manual Contouring in Radiomic Models for Lymph Node Assessment in Esophageal Squamous Cell Carcinoma

  Speaker: Junyi He, BS - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, China, Jinan
• 05:00pm - 06:00pm PT

  Dissecting Cellular Dynamics Following Radiation-Induced Lung Injury via Single-Cell RNA Sequencing

  Speaker: Wenhui Yang, - Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, 430060, China., wuhan
• 05:00pm - 06:00pm PT

  Oncopathological Study on Radiation-Induced Anti-Tumor Immunity in Pancreatic Cancer Treated with Neoadjuvant Chemoradiotherapy

  Speaker: Kazuma Umemiya, MD - Fukushima Medical University, Fukushima-city 960-1295
• 05:00pm - 06:00pm PT

  Local FLASH Radiation Exhibits Double-Edged Effect in Mice Immune System

  Speaker: Xiaohang Qin, - School of Biomedical Engineering, Capital Medical University, Beijing
• 05:00pm - 06:00pm PT

  Pretherapy Radiobiological Dosimetry Using Self-Calibrating Quantitative Hybrid Imaging for Metastatic Thyroid Cancer Treatment with ¹³¹I

  Speaker: Jungwook Shin, PhD - National Cancer Institute, Rockville
• 05:00pm - 06:00pm PT

  Molybdenum Oxide Nanoparticles Alleviates Radiation-Induced Enteritis by Restoring H2S Homeostasis

  Speaker: Jie Zhou, - Sichuan Cancer Hospital and Institute, Chengdu
• 05:00pm - 06:00pm PT

  Radiotherapy-Induced Myeloid Infiltration in the Visual Pathway: A Histopathologic Analysis

  Speaker: Alex Grosinger, MD, MS - University of Minnesota, Minneapolis
• 05:00pm - 06:00pm PT

  Pan-Cancer Epigenetic CRISPR/Cas9 Screening Identifies Men1 as an Radioresistance Target

  Speaker: Yue Zhao, MD, PhD - China, Chengdu
• 05:00pm - 06:00pm PT

  Rutherrin^® Activated by Radiation Therapy Induces Synergistic Tumor Regression through Direct Destruction and Immune Activation in Multiple Preclinical Cancer Models

  Speaker: Mark Roufaiel, - Theralase Technologies Inc., Toronto
• 05:00pm - 06:00pm PT

  Urine Cell-Free RNA Enables Tumor Tissue-of-Origin Prediction in Genitourinary Cancers

  Speaker: Pradeep Chauhan, PhD - Mayo Clinic Rochester, Rochester
• 05:00pm - 06:00pm PT

  Barriers to Medical Translation in Patients Receiving Radiation Therapy

  Speaker: Aviva Berkowitz, MD - Westchester Medical Center, Valhalla
• 05:00pm - 06:00pm PT

  Mitochondrial Pyruvate Carrier as a Potential Therapeutic Target for Radiomodulation of PDAC

  Speaker: Stacey Krepel, BS - KUMC, Branford
• 05:00pm - 06:00pm PT

  Correlation between Linear Energy Transfer and Adverse Events in Intensity-Modulated Proton Therapy

  Speaker: Daniela Branco, PhD - California Protons Cancer Therapy Center, San Diego
• 05:00pm - 06:00pm PT

  ATR Inhibition as a Radiosensitization Strategy in Naturally Occurring Feline Head and Neck Squamous Cell Carcinoma

  Speaker: Michael Nolan, DVM, PhD - North Carolina State University, Raleigh
• 05:00pm - 06:00pm PT

  Optimizing Spatial Fractionation with Sensitizing Agents and Stromal Cell Immune Function

  Speaker: Amie Brint, BS - UAMS Radiation Oncology, Little Rock
• 05:00pm - 06:00pm PT

  A Universal Surviving Model across Multiple Radiation Types Based on Double-Strand Breaks

  Speaker: Miao Qi, - Johns Hopkins University, Baltimore
• 05:00pm - 06:00pm PT

  A Multi-Institutional Evaluation of a Novel PET and Dose Congruence (PDC) Metric for Biology-Guided Radiotherapy

  Speaker: Murat Surucu, PhD - Stanford University School of Medicine, Palo Alto
• 05:00pm - 06:00pm PT

  Impact of KRAS Mutation Status on Long-Term Oncological Outcomes in Unresectable Stage III NSCLC Treated with Chemoradiation with or without Immunotherapy

  Speaker: Ritesh Kumar, MD - Rutgers Cancer Institute of New Jersey, New Brunswick
• 05:00pm - 06:00pm PT

  Preclinical Evaluation of a Novel In Situ Biomimetic Mineralization Radioprotective Absorbable Gel for Prostate Cancer Radiotherapy

  Speaker: Mingwei Ma, MD - Peking University First Hospital, Beijing
• 05:00pm - 06:00pm PT

  Palmitoylation of Sting Promotes Immune Activation and Reformulates Antitumor Immunity following Radiation

  Speaker: Bin Wang, - The First Hospital of Jilin University, Changchun
• 05:00pm - 06:00pm PT

  Maximizing Tumor Growth Delay: The Impact of Carbamide Peroxide Catalysis in Megavoltage Radiodynamic Therapy with 5-Aminolevulinic Acid

  Speaker: Dae-Myoung Yang, PhD - Fox Chase Cancer Center, Cheltenham
• 05:00pm - 06:00pm PT

  Meeting Patients Where They Are: Documentation of SDOH in Radiation Oncology

  Speaker: Claudia Melendez, - University of Utah, Salt Lake City
• 05:00pm - 06:00pm PT

  Radiobiological Modeling of Dose Distributions over Time and Space to Predict Tumor Control and Normal Tissue Response in Spatially Fractionated (GRID) Therapy to Bulky Breast and Chest Wall Tumors

  Speaker: Yash Somnay, MD, PhD - Wayne State University School of Medicine, Detroit
• 05:00pm - 06:00pm PT

  Exploiting Radiation-Activated Prodrugs to Target Antioxidant-Driven Radioresistance

  Speaker: Sedra Mohammadi, MD - Massachusetts General Hospital, Harvard Medical School, Boston
• 05:00pm - 06:00pm PT

  Neurocognitive Evaluation Following Image-Guided Pencil-Beam Scanning Proton FLASH

  Speaker: Chanel Hutchison, - Johns Hopkins, Baltimore
• 05:00pm - 06:00pm PT

  Akt Inhibitors Sensitize Pancreatic Cancers to Radiation Therapy by Enhancing Oxidative Stress, Reversing EMT, and Reprogramming the Immune Microenvironment

  Speaker: Prapannajeet Biswal, MBBS - The University of Texas Health Science Center at Houston, Houston
• 05:00pm - 06:00pm PT

  Ferroptotic Potentiation of Radiation for the Treatment of Pancreatic Ductal Adenocarcinoma

  Speaker: Joseph Carmicheal, MD, PhD - University of Nebraska Medical Center, Omaha
• 05:00pm - 06:00pm PT

  Impact of Dose, Time, and Increasing Gaps in Dose Delivery on the FLASH Effect

  Speaker: Qianyi Huang, MD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston
• 05:00pm - 06:00pm PT

  The Inflammatory State of the Heart at the Time of Radiotherapy may Drive Cardiotoxic vs. Therapeutic Responses

  Speaker: Hamidreza Hajirezaei, - Washington University in St. Louis, St. Louis
• 05:00pm - 06:00pm PT

  Modulating Non-Canonical Neddylation of TGFßRII to Enhance Radiotherapy Response in Oral Squamous Cell Carcinoma

  Speaker: Hsin-Lun Lee, - Taipei Medical University, Taipei City
• 05:00pm - 06:00pm PT

  Importance of Mechanical Homeostasis in Breast Metastatic Reactivation

  Speaker: Jaewook Joo, PhD - Cleveland Clinic Taussig Cancer Center, Cleveland
• 05:00pm - 06:00pm PT

  ?????????????????????????????:??????????

  Speaker: Jialin Feng, - Peking University Cancer Hospital, Beijing
• 05:00pm - 06:00pm PT

  Paid Medical Leave and Access to Care and Financial Hardship among Working Cancer Survivors

  Speaker: Abigail Kohut-Jackson, BS, MBS - Saint Louis University School of Medicine, Saint Louis
• 05:00pm - 06:00pm PT

  Timing and Predictors of Grade 3 Lymphopenia in Lung Cancer Patients Undergoing Proton Chemoradiotherapy

  Speaker: Eyub Yasar Akdemir, MD - Baptist Health, Miami
• 05:00pm - 06:00pm PT

  Human Papillomavirus Vaccine Availability in Korean American Clinics in Southern California: A 10-Year Follow-up Study

  Speaker: Michelle Lee, - USC, Los Angeles
• 05:00pm - 06:00pm PT

  Geographic Distribution of Radiation Oncology Workforce in Underserved Regions: A Cross-Specialty Analysis

  Speaker: Forrest Kwong, MD - MD Anderson Cancer Center, Houston
• 05:00pm - 06:00pm PT

  Language Translation Service Utilization Among Limited English Proficiency Oncology Patients

  Speaker: Yen-Ruh Wuu, MD - Northwell Health, Lake Success
• 05:00pm - 06:00pm PT

  Healthcare Deserts in California: Access to Gynecological HDR

  Speaker: Margaret Barker, MS - MemorialCare Long Beach Medical Center, Long Beach
• 05:00pm - 06:00pm PT

  Unveiling the Burden of Cervical Cancer in Egypt: Incidence Trends, HPV Association, and the Urgent Need for Prevention

  Speaker: Ahmed Nawwar, MD, MPH - Kansas City University, Boston
• 05:00pm - 06:00pm PT

  Racial and Socioeconomic Disparities in the Receipt of Guideline-Concordant Radiation Therapy for Head and Neck Squamous Cell Carcinoma

  Speaker: David Nganga, MD, BS - University of North Carolina Hospitals, Chapel Hill
• 05:00pm - 06:00pm PT

  Disparities in Utilization of Proton Therapy for Pediatric Cancers: An NCDB Analysis

  Speaker: Steve Braunstein, MD, PhD - University of California, San Francisco, San Francisco
• 05:00pm - 06:00pm PT

  Choosing Wisely Bangladesh: Top Ten Practices that Should be Avoided in Cancer Care

  Speaker: Nowshin Hossain, MD - Ahsania Mission Cancer and General Hospital, Dhaka
• 05:00pm - 06:00pm PT

  Identifying Socioeconomic Predictors of Voice Impairment in Long Term Survivors of Locally Advanced Head and Neck Cancer Treated with Radiation Therapy

  Speaker: Adam Hubler, MD - University of Alabama at Birmingham, Birmingham
• 05:00pm - 06:00pm PT

  The Effects of Income and Race in Patients Receiving SRS/FSRT for Brain Metastases: A Single Institution Retrospective Cohort

  Speaker: Lucas Serra, MD, MS - University of Chicago, Chicago
• 05:00pm - 06:00pm PT

  Neighborhood Trajectory as a Predictor for Proximity to Radiation Therapy

  Speaker: Colin McNamara, MSN - Dartmouth Geisel School of Medicine, Lebanon
• 05:00pm - 06:00pm PT

  From Marie Curie to Modern Equity: Advancing Gender Diversity in Radiation Oncology

  Speaker: Catherine Toal, - New York Medical College, Valhalla
• 05:00pm - 06:00pm PT

  Geographic and Demographic Trends in Head and Neck Cancer Mortality in the United States (1999-2020)

  Speaker: Perisa Ashar, BS - Duke University, Durham
• 05:00pm - 06:00pm PT

  Racial and Ethnic Diversity in the Radiation Oncology Pipeline: A Comparative Analysis of the U.S. Cancer Population, Medical School Matriculants and Radiation Oncology Residency

  Speaker: David Haner Wasserstein, BS - New York Medical College, Valhalla
• 05:00pm - 06:00pm PT

  Health-Related Social Risks (HRSR) and Psychosocial Needs Among Patients with Breast Cancer Treated with Radiation

  Speaker: Kamaria Lee, MD - MD Anderson Cancer Center, Houston
• 05:00pm - 06:00pm PT

  Patient Satisfaction and Improvement Needs in Radiation Oncology Telemedicine Consultation: A Pilot Study

  Speaker: Sophia Shah, BS - Christiana Care Health Systems, Newark
• 05:00pm - 06:00pm PT

  Identifying Age, Race, and Sex Biases in Public Imaging and Genomic Datasets for Radiotherapy Patients

  Speaker: Joseph Bae, MS, BS - Stony Brook University, Stony Brook
• 05:00pm - 06:00pm PT

  A Biomimetic Drug Delivery System by Surface-Engineered Exosomes for Glioma Dual-Mode Therapy

  Speaker: Yang Zhang, DSc, PhD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing
• 05:00pm - 06:00pm PT

  Enabling Preclinical, Quantitative, In-Vitro Studies of Hypoxia with MRI with Novel Application of Microfluidic Chips

  Speaker: Clara Fallone, PhD - Department of Medical Physics, Nova Scotia Health, Halifax
• 05:00pm - 06:00pm PT

  Intergrating Radiosensitivity Index and Radiation Resistance Related Index Improves Prostate Cancer Outcome Prediction

  Speaker: Qi-Qiao Wu, MD, PhD Candidate - Fudan Univerisity Zhongshan Hospital(Xiamen), Xiamen
• 05:00pm - 06:00pm PT

  LAG-3 Blockade Enhances the Anti-Tumor Efficacy of PD-1 Blockade Combined with Radiotherapy in a Syngeneic Murine Triple-Negative Breast Cancer Model

  Speaker: In Ah Kim, MD, PhD - Seoul National University Bundang Hospital, Seongnamsi
• 05:00pm - 06:00pm PT

  Pathological Features of Radiation-Induced Liver Disease in a Normal Rat Model

  Speaker: Feng Zhao, MD, PhD - The First affiliated Hospital Zhejiang University School of Medicine, Hangzhou
• 05:00pm - 06:00pm PT

  A Nested Case-Control Study to Identify Candidate Biomarkers that Predict Radioresistance in Cervical Cancer

  Speaker: Takahiro Oike, MD, PhD - Gunma University, Maebashi
• 05:00pm - 06:00pm PT

  Prediction of PACIFIC Regimen Efficacy by Measuring Serum Autoantibody Response Against Cancer Antigens Using the MUSCAT Assay

  Speaker: Masanori Someya, MD, PhD - Sapporo Medical University, Sapporo
• 05:00pm - 06:00pm PT

  Questionnaire Survey on Radiotherapy Practice in a Rural Prefecture in Japan: Factors Affecting Indication Rates of Radiotherapy

  Speaker: Yuki Wada, MD, PhD - Akita University Graduate School of Medicine, Akita
• 05:00pm - 06:00pm PT

  Liposome-Encapsulated Drug Delivery Inhibits Ferroptosis and Alleviates Radiation Injury

  Speaker: Yunan Gao, MS - Zhongshan Hospital Fudan University, Shanghai
• 05:00pm - 06:00pm PT

  Effect of Acute High Dose TBI on RBC Dysfunction and Erythropoiesis in C57BL/6J Mice

  Speaker: Sarayu Valluri, BS - University of Maryland School of Medicine, Annapolis
• 05:00pm - 06:00pm PT

  Exploring the Potential of FLASH Proton Therapy in Medulloblastoma: Insights from Cerebellar and Tumor Organoids

  Speaker: Hiromitsu Iwata, MD, PhD - Nagoya Proton Therapy Center, Nagoya City University West Medical Center, Nagoya
• 05:00pm - 06:00pm PT

  HAT1 Functions as a Lactyltransferase and Mediates RPA1 Lactylation to Promote DNA Repair and Radioresistance in Lung Adenocarcinoma

  Speaker: Jiang He, - College of Bioengineering, Chongqing University, Chongqing, China, Chongqing
• 05:00pm - 06:00pm PT

  Immune Checkpoint Inhibitors Administered Prior to Chemoradiotherapy Increase Radiation-Induced Pneumonitis Risk in Stage III Unresectable NSCLC

  Speaker: Dawei Chen, MD, MB - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan
• 05:00pm - 06:00pm PT

  Transcriptomic Analysis of a Tumor Microarray of Breast Cancers with BRCA1 vs. BRCA2 Mutations

  Speaker: Vladislav Sviderskiy, MD, PhD - Washington University School of Medicine in St. Louis, St. Louis
• 05:00pm - 06:00pm PT

  Analysis of the miRNome Expression Profile in Saliva Samples as a Function of Neoadjuvant Chemoradiotherapy in a Rectal Cancer Study Population Using Next-Generation Sequencing

  Speaker: Kristof Gal, MD, PhD - University of Debrecen,
• 05:00pm - 06:00pm PT

  Nembaleukin a-Enhanced Dual Tumor Attack By Fas-4-1BB Engineered CD8⁺-T-Cell with CAND1 Pubic Neoantigen and Natural Killer Cell, Using Encapsulated Nanoparticles Directed By Radiation

  Speaker: Satoshi Harada, MD, PhD - Iwate Medical University School of Medicine, Shiwa
• 05:00pm - 06:00pm PT

  Assessment of Neutrophil-to-Lymphocyte Ratio Changes in Meningiomas after Conventional Radiotherapy or Radiosurgery

  Speaker: Shubhendu Mishra, MD, MS - University of Minnesota Radiation Oncology Clinic University Campus, Minneapolis
• 05:00pm - 06:00pm PT

  Missed Radiotherapy Visits Following Initiation of Systematic Assessment of Patients Transportation Need

  Speaker: Kathleen Cui, - Department of Radiation Oncology, University of California San Francisco, San Francisco
• 05:00pm - 06:00pm PT

  Realistic Closed-Form TCP Model including Cell Sensitivity Dependence

  Speaker: Sergejs Unterkirhers, DSc, PhD, MS, BS - Radiotherapy Hirslanden, Zurich
• 05:00pm - 06:00pm PT

  The Impact of LET and the Tumor Immune Microenvironment on Differential Response of Genetically Engineered Pancreatic Cancer Models to Carbon Ion Radiotherapy

  Speaker: Henry Meyer, - The University of Texas MD Anderson Cancer Center, Houston
• 05:00pm - 06:00pm PT

  Can We Assess Acute Radiation Injury? Feasibility of Redox Imaging by Dynamic Nuclear Polarized (DNP) MRI

  Speaker: Masayuki Matsuo, MD, PhD - Gifu University, Gifu
• 05:00pm - 06:00pm PT

  Iron Released from Radiation-Induced Apoptotic Cells Activates Neighboring Quiescent Colorectal Cancer Stem Cells to Display Radioresistance

  Speaker: Xiangjun Liu, - Sichuan Cancer Center, Chengdu
• 05:00pm - 06:00pm PT

  INHBA is a Key Mediator of Proton Radiotherapy in Reversing Photon-Induced Radioresistance in Breast Cancer

  Speaker: Zhe Xu, MD - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China, Shanghai
• 05:00pm - 06:00pm PT

  Ligand-Directed Liposomal Carfilzomib as a Radiosensitizer for Non-Small Cell Lung Cancer

  Speaker: Matthew Molinaro, - Pennsylvania State Universtity, University Park
• 05:00pm - 06:00pm PT

  Effect of Sex on <em>Limosilactobacillus Reuteri </em>Releasing IL-22 (LR-IL-22) Mitigation of Gastrointestinal-Acute Radiation Syndrome

  Speaker: Diala Hamade, MD - University of Pittsburgh Medical Center, Pittsburgh
• 05:00pm - 06:00pm PT

  Localized Oxygen Delivery via High-Pressure-Synthesized Oxygen Gas-Entrapping Materials Enhances Radiotherapy Efficacy and Improves Outcomes in Solid Tumors

  Speaker: Uwajachukwumma Uzomah, MD, MPH - University of Iowa Hospitals & Clinics, Iowa City
• 05:00pm - 06:00pm PT

  Systemic immune activation by SARS-CoV-2 mRNA vaccines sensitizes tumors to immune checkpoint blockade

  Speaker: Adam Grippin, MD, PhD - MD Anderson Cancer Center, Houston
• 05:00pm - 06:00pm PT

  Radiotherapy Enhances TROP-2 Antibody Drug Conjugate Efficacy By Upregulating TROP-2 Membrane Expression, and Increasing Apoptosis and DNA Damage

  Speaker: Wen-Chi Yang, MD - National Taiwan University Hospital, Taipei
• 05:00pm - 06:00pm PT

  Genomic Insights into Prostate Cancer Trends in Black/African American Men

  Speaker: Victor Lee, MD, BS - Yale New Haven Hospital, Middletown
• 05:00pm - 06:00pm PT

  Systematic Review on Adult Diagnostic Reference Levels in Computed Tomography, and Analysis of Regional Variability

  Speaker: Abdel-Baset Bani Yaseen, PhD candidate - Queensland University of Technology, Brisbane, QLD
• 05:00pm - 06:00pm PT

  RNA-Sequencing-Derived Radiosensitivity Index for Genomic-Adjusted Radiotherapy

  Speaker: Steven Tau, PhD - Dartmouth College, Hanover
• 05:00pm - 06:00pm PT

  Optimizing Image Quality and Workflow with Gadoxetate Disodium Contrast in MRI-Guided Stereotactic Body Radiotherapy for Liver Metastases

  Speaker: Ari Kassardjian, MD - City of Hope Comprehensive Cancer Center, Duarte
• 05:00pm - 06:00pm PT

  Low Dose Radiation Enhances Anti-Inflammatory Effect of Creatine and Overcomes Type 1 Diabetes-Induced Suppression of Osteogenesis and Angiogenesis

  Speaker: Geng Xiang, - Department of Radiation Oncology, Xijing Hospital, Air Force Medical University, Xi’an
• 05:00pm - 06:00pm PT

  3-Bromopyruvate in Combination with Radiation Inhibits Pancreatic Tumor Growth by Suppressing Hexokinase II (HK2) Enzyme of Aerobic Glycolysis

  Speaker: Hem Shukla, PhD - University of Maryland School of Medicine, Baltimore
• 05:00pm - 06:00pm PT

  HnRNPA1 Regulates MARF1 Alternative Splicing By Interacting with PTBP1 to Enhance the Radioresistance of Oral Squamous Cell Carcinoma

  Speaker: Fantong Xia, - Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China, Chongqing
• 05:00pm - 06:00pm PT

  Single-cell transcriptomics reveals the dynamic changes of tumor-infiltrating immune cells after radiation in Oral squamous cell carcinoma

  Speaker: Fantong Xia, - Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China, Chongqing
• 05:00pm - 06:00pm PT

  Radiobiology of Image-Guided Radiotherapy: In Vitro<em> </em>Radiosensitivity of Lung Cancer following Computed Tomography Exposure

  Speaker: Rana El-Hassan, MS - American University of Beirut, Beirut
• 05:00pm - 06:00pm PT

  Macroscopic and Microscopic Assessment of the Proton-CAT for Practical Radiation Therapy Applications Using Monte Carlo Simulation

  Speaker: JunXiang Wu, PhD, MS - Sichuan Cancer Hospital, Cheng Du
• 05:00pm - 06:00pm PT

  Combining High-Dose Radiation with Dual CCR8 and PD-1 Blockade to Overcome Tumor Immune Suppression

  Speaker: Yun Hu, PhD - MD Anderson Cancer Center, Houston
• 05:00pm - 06:00pm PT

  Current and Projected Gaps in the Global Availability of Brachytherapy for Cervical Cancer

  Speaker: Georgia Harris, MBBS, MPH - Princess Margaret Cancer Centre, Toronto
• 05:00pm - 06:00pm PT

  PA2G4 as a Candidate Therapeutic Target in Pediatric Diffuse Gliomas

  Speaker: Zaid Sirhan, MS, PharmD - The Ohio State University James Cancer Hospital, Columbus
• 05:00pm - 06:00pm PT

  A Pre-Clinical Study of Hyperbaric Oxygen Therapy to Enhance Radiosensitization of Glioblastoma

  Speaker: David Hunter, - Dartmouth College, Hanover
• 05:00pm - 06:00pm PT

  A Novel Physicochemical Model to Elucidate the Mechanism of FLASH Radiotherapy and Identify Optimal Conditions for Sparing Normal Tissue Toxicity

  Speaker: Lixiang Guo, MS, BS - UT Southwestern Medical Center, Dallas
• 05:00pm - 06:00pm PT

  Development of Computational Immunohistochemical Stained Tissue Analysis to Quantitatively Investigate Intracellular Radiochemical Oxygen Depletion in FLASH Irradiated Murine Intestine

  Speaker: Rodney Wiersma, PhD - University of California Los Angeles, Los Angeles
• 05:00pm - 06:00pm PT

  Biomimetic CD47 Red Blood Cell Membrane-Coated Nanoparticles Enhance Spleen Radioprotection in Liver Cancer Radiotherapy

  Speaker: Shigao Huang, MD, PhD - 323 Hospital of Peoples Liberation Army, Xian
• 05:00pm - 06:00pm PT

  Proton-Induced Radiodynamic Therapy Based on PEG-Modified Nano-ZnO Composites and Mechanism of Action

  Speaker: Guoqiang Zhao, PhD - Sichuan Cancer Hospital, Chengdu
• 05:00pm - 06:00pm PT

  Evaluating the Correlation between Genomic Classifier and Digital Pathology-Based Multi-Modal AI Biomarkers in Localized Prostate Cancer

  Speaker: Adeniyi Olabumuyi, MB, BS, MB, BS - University of Maryland Radiation Oncology, Baltimore
• 05:00pm - 06:00pm PT

  Single-pixel approach achieving ultrasensitive in vivo bioluminescence imaging for cancer research

  Speaker: Zhishen Tong, PhD - UT Southwestern Medical Center, Dallas
• 05:00pm - 06:00pm PT

  Evaluation of Proton Flash Irradiation on Cell Survival Under Various Oxygen Concentrations In Vitro

  Speaker: Shinji Nomura, PhD - Sumitomo Heavy Industries, Ltd., Yokosuka
• 05:00pm - 06:00pm PT

  Alaska Native Internship in ONcology (ANION): A Novel Pilot Program Addressing Oncology Workforce Deficits in Alaskan Health Care through Mentorship in Radiation Therapy

  Speaker: Laura Aspelund, BS - University of Washington School of Medicine- Alaska Foundations, Anchorage
• 05:00pm - 06:00pm PT

  The Protective Role and Mechanism of SOCS6 in Radiation-Induced Lung Injury via mtDNA/cGAS/STING Signaling Axis-Mediated Pyroptosis

  Speaker: Rui Ma, MS - Xijing Hospital, Air Force Medical University, Xi’an
• 05:00pm - 06:00pm PT

  Reversing Radioresistance in Hepatocellular Carcinoma by Targeting Autophagy and Cancer Stem Cells via the CD44/mTOR Signaling Axis

  Speaker: Yu-Wei Lin, MD, PhD, MS - Kaohsiung Veterans General Hospital, Kaohsiung
• 05:00pm - 06:00pm PT

  P53 Downregulation-Based Strategy to Reduce Radiation-Induced Secondary Malignancies: A Pilot Study with RF Mice

  Speaker: Hang Su, PhD - UTHSCSA, san antonio
• 05:00pm - 06:00pm PT

  Translational Relevance of SOX2 and OCT4 as Mediators of Treatment Resistance in Pancreatic Cancer

  Speaker: Zachery Keepers, BS - University of Maryland School of Medicine, Baltimore
• 05:00pm - 06:00pm PT

  Kat5 as a Prognostic Biomarker and Therapeutic Target in Esophageal Squamous Cell Carcinoma

  Speaker: Qing Chen, RT - The Second Affiliated Hospital of Soochow University, Suzhou
• 05:00pm - 06:00pm PT

  Development of Honokiol Prodrug in Alleviating Myocardial Mitochondrial Dysfunction and Restrictive Cardiomyopathy after Irradiation

  Speaker: Won Suk Jahng, PhD - Stanford University, San Jose
• 05:00pm - 06:00pm PT

  Combined Oxygen Ion Beam Irradiation and Gemcitabine Treatment of Pancreatic Cancer - An In Vitro Investigation

  Speaker: Lixin Mai, MD - German Cancer Research Center (DKFZ), Heidelberg
• 05:00pm - 06:00pm PT

  NLRP3 Inflammasome-Mediated Residual Tumor Cell Repopulation Promotes Radioresistance in Gastric Cancer

  Speaker: Shuyan Li, PhD - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
• 05:00pm - 06:00pm PT

  Caffeine-Enhanced Radiation-Mediated G2/M Phase Arrest through ATM/?H2AX/Chk2 Signaling in Human Hepatoma Cells

  Speaker: Yu-Wei Lin, MD, PhD, MS - Kaohsiung Veterans General Hospital, Kaohsiung
• 05:00pm - 06:00pm PT

  Early Biological Response in Cardiac Toxicity: Comparison of Proton and Photon Irradiation

  Speaker: Keman Liao, - Department of Radiation Oncology, Ruijin Hospital, Shang- hai Jiao Tong University School of Medicine, shanghai
• 05:00pm - 06:00pm PT

  Comparison of Perceptions of Barriers to Advancement for Women in Radiation Oncology among Different Practice Settings

  Speaker: Ziyi Huang, MD - City of Hope, Upland
• 05:00pm - 06:00pm PT

  Genomic Biomarkers of Radiation Sensitivity

  Speaker: Anna Dos Santos, BS - Robert Wood Johnson Medical School, New Brunswick
• 05:00pm - 06:00pm PT

  Injectable Adipose-Derived Mesenchymal Stem Cell Exosome-Hydrogel System for Enhancing Radiosensitivity in Hepatocellular Carcinoma: Mechanisms and Effects

  Speaker: Lingyun Wu, MD - Zhejiang University, Hangzhou
• 05:00pm - 06:00pm PT

  Prospective Serum Lipidomic Profiling Identifies Predictive Biomarkers for nCRT Response and Tumor Regression in Advanced Esophageal Cancer

  Speaker: Zheng Mei, - Department of Radiation oncology, Radiation Oncology KeyLaboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, SichuanCancerCenter, Universit, Chengdu
• 05:00pm - 06:00pm PT

  EHD1-Driven Radioresistance in Hepatocellular Carcinoma: Hippo Pathway Regulation and Immune Microenvironment Remodeling

  Speaker: Lingyun Wu, MD - Zhejiang University, Hangzhou
• 05:00pm - 06:00pm PT

  CDK15 Promotes Esophageal Squamous Cell Carcinoma Progression by Phosphorylating HK₂ and Regulating Glycolysis

  Speaker: Hong Ge, MD - Henan Cancer Hospital, Zhengzhou
• 05:00pm - 06:00pm PT

  Small Molecule G07 Exhibits Dual Effects on Cell Motility by Enhancing Skin Wound Healing and Inhibiting Nasopharyngeal Carcinoma Metastasis

  Speaker: Lingling Guo, MD - Peking University Shenzhen Hospital, Shenzhen
• 05:00pm - 06:00pm PT

  Targeting CD244 Enhances Radiotherapy Response through Modulation of Tumor Immune Microenvironment

  Speaker: Jialin Zhou, - Shandong University Cancer Center, Jinan
• 05:00pm - 06:00pm PT

  UBE2O Targets CDKL1 for Ubiquitination and Degradation to Induce PD-L1 Expression and Confer Radioimmunotherapy Resistance in Lung Cancer

  Speaker: Shuangbing Xu, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
• 05:00pm - 06:00pm PT

  Chromosomal Aberrations in Peripheral Blood Lymphocytes as Predictive Biomarkers for Severe Adverse Events in Thoracic Definitive Chemoradiotherapy

  Speaker: Nobuki Imano, MD, PhD - Hiroshima University, Hiroshima
• 05:00pm - 06:00pm PT

  Knockdown and Inhibition of RNA-Binding Proteins Musashi-1 and Musashi-2 Modulate DNA Repair and Radiosensitize Triple-Negative Breast Cancer

  Speaker: Fabian Troschel, MD - Muenster University, Muenster
• 05:00pm - 06:00pm PT

  The Effect of Residing in a Food-Insecure Area on Locally Advanced Breast Cancer Survival

  Speaker: Lei Hugh Escobal, BS - University of Maryland School of Medicine, Baltimore
• 05:00pm - 06:00pm PT

  Tumor Microenvironment Characterization and Outcome Prediction in Concurrent Radiation Therapy and Immunotherapy Using CODEX

  Speaker: Hao Peng, PhD - UT Southwestern Medical Center, Dallas
• 05:00pm - 06:00pm PT

  Bystander Effect of Exosomal miR-3065-5p Inhibits Lung Cancer Cells by Suppressing Radiation-Induced Profilin 2

  Speaker: Jaeha Lee, MD - Asan Medical Center, Seoul 138-736